It has generally been thought that lymphomas in humans and dogs acquire multidrug resistance from the continuous activation of drug transporters, such as ABCB1 and ABCG2, after long-term exposure to anticancer drugs, inducing chemical tolerance in the patient [3, 27]. This evidence concerns the gene ABCB1 and lymphoma.